Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Pino, Poddighe"'
Autor:
Alexander C. Leeksma, Panagiotis Baliakas, Theodoros Moysiadis, Anna Puiggros, Karla Plevova, Anne-Marie van der Kevie-Kersemaekers, Hidde Posthuma, Ana E. Rodriguez-Vicente, Anh Nhi Tran, Gisela Barbany, Larry Mansouri, Rebeqa Gunnarsson, Helen Parker, Eva van den Berg, Mar Bellido, Zadie Davis, Meaghan Wall, Ilaria Scarpelli, Anders Österborg, Lotta Hansson, Marie Jarosova, Paolo Ghia, Pino Poddighe, Blanca Espinet, Sarka Pospisilova, Constantine Tam, Loïc Ysebaert, Florence Nguyen-Khac, David Oscier, Claudia Haferlach, Jacqueline Schoumans, Marian Stevens-Kroef, Eric Eldering, Kostas Stamatopoulos, Richard Rosenquist, Jonathan C. Strefford, Clemens Mellink, Arnon P. Kater
Publikováno v:
Haematologica, Vol 106, Iss 1 (2020)
Complex karyotype (CK) identified by chromosome-banding analysis (CBA) has shown prognostic value in chronic lymphocytic leukemia (CLL). Genomic arrays offer high-resolution genome-wide detection of copy-number alterations (CNAs) and could therefore
Externí odkaz:
https://doaj.org/article/b0edf60d944d4c6fab629017cf3cd09c
Autor:
Maria B.L. Leijs, Pieter Sonneveld, Bronno van der Holt, Marian Stevens-Kroef, Per Axelsson, Niels Abildgaard, Markus Hansson, Pino Poddighe, Saskia K. Klein, Anders Waage, Sonja Zweegman, Dorota Knut-Bojanovska, Asta Svirskaite, Einar Haukås, Mark-David Levin, Fredrik Schjesvold, Damian L. Szatkowski, Niels W.C.J. van de Donk, Trung Hieu Do, Claudia A.M. Stege, Ellen van der Spek
Publikováno v:
Zweegman, S, Schjesvold, F H, van der Holt, B, Levin, M-D, Stege, C A M, Waage, A, Leijs, M B L, Klein, S K, Szatkowski, D L, Axelsson, P, Do, T H, Knut-Bojanovska, D, van der Spek, E, Svirskaite, A, Poddighe, P, Stevens-Kroef, M, Hansson, M, van de Donk, N W C J, Haukas, E, Sonneveld, P & Abildgaard, N 2018, ' Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Results from the Randomized Phase II HOVON-126/Nmsg 2113 Trial ', Blood, vol. 132, no. Suppl. 1 . https://doi.org/10.1182/blood-2018-99-111650
Zweegman, S, Schjesvold, F H, van der Holt, B, Levin, M-D, Stege, C A M, Waage, A, Leijs, M B L, Klein, S K, Szatkowski, D L, Axelsson, P, Do, T H, Knut-Bojanovska, D, van der Spek, E, Svirskaite, A, Poddighe, P, Stevens-Kroef, M, Hansson, M, van de Donk, N W C J, Haukas, E, Sonneveld, P & Abildgaard, N 2018, ' Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Results from the Randomized Phase II HOVON-126/Nmsg 21#13 Trial ', Blood, vol. 132, no. Suppl. 1, pp. 800-800 . https://doi.org/10.1182/blood-2018-99-111650
Zweegman, S, Schjesvold, F H, van der Holt, B, Levin, M-D, Stege, C A M, Waage, A, Leijs, M B L, Klein, S K, Szatkowski, D L, Axelsson, P, Do, T H, Knut-Bojanovska, D, van der Spek, E, Svirskaite, A, Poddighe, P, Stevens-Kroef, M, Hansson, M, van de Donk, N W C J, Haukas, E, Sonneveld, P & Abildgaard, N 2018, ' Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Results from the Randomized Phase II HOVON-126/Nmsg 21#13 Trial ', Blood, vol. 132, no. Suppl. 1, pp. 800-800 . https://doi.org/10.1182/blood-2018-99-111650
Introduction A triplet combination including a proteasome inhibitor (PI) and an IMiD has shown significant efficacy in newly diagnosed multiple myeloma (NDMM) patients. A role for maintenance therapy with the PI bortezomib has been suggested in non-h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ceeda16a8771971fe347d1cbf1046e5
https://portal.findresearcher.sdu.dk/da/publications/e77b2b7e-45e9-46e3-8538-b5ea1c4d970d
https://portal.findresearcher.sdu.dk/da/publications/e77b2b7e-45e9-46e3-8538-b5ea1c4d970d
Autor:
Tom G H, Wiggers, Guus, Westra, Theresia M, Westers, Andre P, Abbes, Annuska, Strunk, Ellen, Kuiper-Kramer, Pino, Poddighe, Arjan A, van de Loosdrecht, Martine E D, Chamuleau
Publikováno v:
Cytometry. Part B, Clinical cytometry.
The strongest prognostic factor in chronic B-cell lymphocytic leukaemia (CLL) is the mutational status of the immunoglobulin heavy chain variable region (IGHV) genes. Determination of this mutational status is laborious and therefore not applied in r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6dc074d4687459a557303443d13ec290
https://pubmed.ncbi.nlm.nih.gov/24124110
https://pubmed.ncbi.nlm.nih.gov/24124110
Autor:
Peter L. Pearson, Arjan Buijs, Anton Hagenbeek, Richard van Wijk, Leo F. Verdonck, Wouter W. van Solinge, Pino Poddighe, Eric Borst, Henk M. Lokhorst
Publikováno v:
Blood. 98:2856-2858
Hereditary mutations associated with hematologic malignancies are rare. Heterozygous mutations affecting the hematopoietic transcription factor CBFA2 (also AML1/RUNX1) were recently reported to be associated with familial platelet disorder with predi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1396713ef1cdb1eca175a71960c9bcdc
https://doi.org/10.1182/blood.v98.9.2856
https://doi.org/10.1182/blood.v98.9.2856